Prophylactic von Willebrand factor replacement in durable left ventricular assist device patients: a sticky subject

Puntos clave

• Prophylactic von Willebrand factor replacement reduces bleeding risk in patients with left ventricular assist devices.
• Patients experienced a decrease in major bleeding events by 40% over a 12-month period.
• Observational analysis across multiple healthcare centers assessed bleeding incidents and factors affecting coagulation.
• Findings suggest the need for larger trials to validate these strategies in diverse clinical settings.